Article
Gilead, US square off in billion-dollar HIV drug patent trial
Rating:
0.0
Views:
83
Likes:
1
Library:
1
Gilead Sciences Inc is headed to trial in Delaware federal court this week to fight claims that it owes the U.S. government a share of multibillion-dollar profits from its HIV-prevention drug regimen.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value